PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 1KNO

#CDRs = 8; #Clusters = 8.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
A	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L1	11	L1-11-2	16	RASQEISGYLS	BBABBALLABB
A	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L2	8	L2-8-1	19	YAASTLDS	BLLABBBB
A	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	85.7	L3	9	L3-9-2	17	LQYASSPYT	BBAABABBB
A	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L4	6	L4-6-2	10	RSGSDY	BBEABB
B	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H1	13	H1-13-1	16	AASGFTFSSFGMH	BBBLBBAAABBBB
B	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H2	10	H2-10-*	-1	YISSGSSTIY	BBBAALBEBB
B	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H3	12	H3-12-*	-1	ARGDYYGSRGAY	BBBLABLAEBBB
B	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H4	8	H4-8-1	12	RDNPKNTL	BBAAALBB
C	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L1	11	L1-11-2	16	RASQEISGYLS	BBABBALLABB
C	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L2	8	L2-8-1	17	YAASTLDS	BLLABBBB
C	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	85.7	L3	9	L3-9-2	20	LQYASSPYT	BBAABABBB
C	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L4	6	L4-6-2	11	RSGSDY	BBEABB
D	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H1	13	H1-13-1	14	AASGFTFSSFGMH	BBBLBBAAABBBB
D	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H2	10	H2-10-*	-1	YISSGSSTIY	BBBAALAEBB
D	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H3	12	H3-12-*	-1	ARGDYYGSRGAY	BBBLABEAEBBB
D	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H4	8	H4-8-1	13	RDNPKNTL	BBAAALBB
E	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L1	11	L1-11-2	17	RASQEISGYLS	BBABBALLABB
E	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L2	8	L2-8-1	15	YAASTLDS	BLLABBBB
E	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	85.7	L3	9	L3-9-2	20	LQYASSPYT	BBAABABBB
E	kappa	Mus.musculus	Mo_IGKV9-124*01	100.0	Mo_IGKV9-124*01	100.0	L4	6	L4-6-2	12	RSGSDY	BBEABB
F	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H1	13	H1-13-1	13	AASGFTFSSFGMH	BBBLBBAAABBBB
F	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H2	10	H2-10-*	-1	YISSGSSTIY	BBBAALBEBB
F	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H3	12	H3-12-*	-1	ARGDYYGSRGAY	BBBLABLAEBBB
F	heavy	Mus.musculus	Mo_IGHV5-17*02	98.6	Mo_IGHV5-17*02	100.0	H4	8	H4-8-1	14	RDNPKNTL	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022